The peptide problem: Hype is outrunning the evidence FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law What are peptides? The treatments promising weight loss and better skin, explained Vox Subcutaneous Injection Sites and Instructions for Safe Self Administration